{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:19:24Z","timestamp":1780323564896,"version":"3.54.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"24","license":[{"start":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T00:00:00Z","timestamp":1318809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T00:00:00Z","timestamp":1318809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2012,6,14]]},"DOI":"10.1038\/onc.2011.470","type":"journal-article","created":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T10:41:08Z","timestamp":1318848068000},"page":"3002-3008","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":135,"title":["Myc represses miR-15a\/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas"],"prefix":"10.1038","volume":"31","author":[{"given":"X","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Lwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L C","family":"Moscinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W S","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Seto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Sotomayor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,17]]},"reference":[{"key":"BFonc2011470_CR1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/cdd.2009.69","volume":"17","author":"RI Aqeilan","year":"2010","unstructured":"Aqeilan RI, Calin GA, Croce CM . (2010). miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ 17: 215\u2013220.","journal-title":"Cell Death Differ"},{"key":"BFonc2011470_CR2","doi-asserted-by":"publisher","first-page":"5553","DOI":"10.1158\/0008-5472.CAN-08-4277","volume":"69","author":"N Bandi","year":"2009","unstructured":"Bandi N, Zbinden S, Gugger M, Arnold M, Kocher V, Hasan L et al. (2009). miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Res 69: 5553\u20135559.","journal-title":"Cancer Res"},{"key":"BFonc2011470_CR3","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1200\/JCO.2009.26.3947","volume":"28","author":"S Barrans","year":"2010","unstructured":"Barrans S, Crouch S, Smith A, Turner K, Owen R, Patmore R et al. (2010). Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab. J Clin Oncol 28: 3360\u20133365.","journal-title":"J Clin Oncol"},{"key":"BFonc2011470_CR4","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1200\/JCO.2005.16.600","volume":"23","author":"KN Bhalla","year":"2005","unstructured":"Bhalla KN . (2005). Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies. J Clin Oncol 23: 3971\u20133993.","journal-title":"J Clin Oncol"},{"key":"BFonc2011470_CR5","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/nm.1880","volume":"14","author":"D Bonci","year":"2008","unstructured":"Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L et al. (2008). The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 14: 1271\u20131277.","journal-title":"Nat Med"},{"key":"BFonc2011470_CR6","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/jcp.20282","volume":"204","author":"A Bottoni","year":"2005","unstructured":"Bottoni A, Piccin D, Tagliati F, Luchin A, Zatelli MC, degli Uberti EC . (2005). miR-15a and miR-16-1 down-regulation in pituitary adenomas. J Cell Physiol 204: 280\u2013285.","journal-title":"J Cell Physiol"},{"key":"BFonc2011470_CR7","doi-asserted-by":"publisher","first-page":"15524","DOI":"10.1073\/pnas.242606799","volume":"99","author":"GA Calin","year":"2002","unstructured":"Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. (2002). Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99: 15524\u201315529.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2011470_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/ng.2007.30","volume":"40","author":"TC Chang","year":"2008","unstructured":"Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM et al. (2008). Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 40: 43\u201350.","journal-title":"Nat Genet"},{"key":"BFonc2011470_CR9","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/nrg2634","volume":"10","author":"CM Croce","year":"2009","unstructured":"Croce CM . (2009). Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10: 704\u2013714.","journal-title":"Nat Rev Genet"},{"key":"BFonc2011470_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1749-6632.2009.05121.x","volume":"1183","author":"J Davidson-Moncada","year":"2010","unstructured":"Davidson-Moncada J, Papavasiliou FN, Tam W . (2010). MicroRNAs of the immune system: roles in inflammation and cancer. Ann NY Acad Sci 1183: 183\u2013194.","journal-title":"Ann NY Acad Sci"},{"key":"BFonc2011470_CR11","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1101\/gad.906601","volume":"15","author":"SR Frank","year":"2001","unstructured":"Frank SR, Schroeder M, Fernandez P, Taubert S, Amati B . (2001). Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev 15: 2069\u20132082.","journal-title":"Genes Dev"},{"key":"BFonc2011470_CR12","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nrd3179","volume":"9","author":"R Garzon","year":"2010","unstructured":"Garzon R, Marcucci G, Croce CM . (2010). Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 9: 775\u2013789.","journal-title":"Nat Rev Drug Discov"},{"key":"BFonc2011470_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrg2485","volume":"10","author":"M Haberland","year":"2009","unstructured":"Haberland M, Montgomery RL, Olson EN . (2009). The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 10: 32\u201342.","journal-title":"Nat Rev Genet"},{"key":"BFonc2011470_CR14","first-page":"1284","volume":"6","author":"L Han","year":"2007","unstructured":"Han L, Witmer PD, Casey E, Valle D, Sukumar S . (2007). DNA methylation regulates microRNA expression. Cancer Biol Ther 6: 1284\u20131288.","journal-title":"Cancer Biol Ther"},{"key":"BFonc2011470_CR15","doi-asserted-by":"publisher","first-page":"4966","DOI":"10.1200\/JCO.2007.12.0410","volume":"26","author":"E Hartmann","year":"2008","unstructured":"Hartmann E, Fernandez V, Moreno V, Valls J, Hernandez L, Bosch F et al. (2008). Five-gene model to predict survival in mantle-cell lymphoma using frozen or formalin-fixed, paraffin-embedded tissue. J Clin Oncol 26: 4966\u20134972.","journal-title":"J Clin Oncol"},{"key":"BFonc2011470_CR16","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1038\/sj.leu.2401599","volume":"13","author":"L Hernandez","year":"1999","unstructured":"Hernandez L, Hernandez S, Bea S, Pinyol M, Ferrer A, Bosch F et al. (1999). c-myc mRNA expression and genomic alterations in mantle cell lymphomas and other nodal non-Hodgkin's lymphomas. Leukemia 13: 2087\u20132093.","journal-title":"Leukemia"},{"key":"BFonc2011470_CR17","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.1158\/0008-5472.CAN-07-6552","volume":"68","author":"JF Kurland","year":"2008","unstructured":"Kurland JF, Tansey WP . (2008). Myc-mediated transcriptional repression by recruitment of histone deacetylase. Cancer Res 68: 3624\u20133629.","journal-title":"Cancer Res"},{"key":"BFonc2011470_CR18","first-page":"45","volume":"24","author":"EM Lee","year":"2009","unstructured":"Lee EM, Shin S, Cha HJ, Yoon Y, Bae S, Jung JH et al. (2009). Suberoylanilide hydroxamic acid (SAHA) changes microRNA expression profiles in A549 human non-small cell lung cancer cells. Int J Mol Med 24: 45\u201350.","journal-title":"Int J Mol Med"},{"key":"BFonc2011470_CR19","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1016\/j.yexcr.2009.07.001","volume":"315","author":"M Lerner","year":"2009","unstructured":"Lerner M, Harada M, Loven J, Castro J, Davis Z, Oscier D et al. (2009). DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1. Exp Cell Res 315: 2941\u20132952.","journal-title":"Exp Cell Res"},{"key":"BFonc2011470_CR20","doi-asserted-by":"publisher","first-page":"18682","DOI":"10.1073\/pnas.0705524104","volume":"104","author":"T Liu","year":"2007","unstructured":"Liu T, Tee AE, Porro A, Smith SA, Dwarte T, Liu PY et al. (2007). Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis. Proc Natl Acad Sci USA 104: 18682\u201318687.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2011470_CR21","doi-asserted-by":"publisher","first-page":"5957","DOI":"10.1038\/onc.2010.332","volume":"29","author":"GM Marshall","year":"2010","unstructured":"Marshall GM, Gherardi S, Xu N, Neiron Z, Trahair T, Scarlett CJ et al. (2010). Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects. Oncogene 29: 5957\u20135968.","journal-title":"Oncogene"},{"key":"BFonc2011470_CR22","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/nrc2231","volume":"8","author":"N Meyer","year":"2008","unstructured":"Meyer N, Penn LZ . (2008). Reflecting on 25 years with MYC. Nat Rev Cancer 8: 976\u2013990.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2011470_CR23","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1046\/j.1365-2141.2003.04121.x","volume":"120","author":"B Nagy","year":"2003","unstructured":"Nagy B, Lundan T, Larramendy ML, Aalto Y, Zhu Y, Niini T et al. (2003). Abnormal expression of apoptosis-related genes in haematological malignancies: overexpression of MYC is poor prognostic sign in mantle cell lymphoma. Br J Haematol 120: 434\u2013441.","journal-title":"Br J Haematol"},{"key":"BFonc2011470_CR24","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nature03677","volume":"435","author":"KA O'Donnell","year":"2005","unstructured":"O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT . (2005). c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839\u2013843.","journal-title":"Nature"},{"key":"BFonc2011470_CR25","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6","volume":"87","author":"A Pajic","year":"2000","unstructured":"Pajic A, Spitkovsky D, Christoph B, Kempkes B, Schuhmacher M, Staege MS et al. (2000). Cell cycle activation by c-myc in a Burkitt lymphoma model cell line. Int J Cancer 87: 787\u2013793.","journal-title":"Int J Cancer"},{"key":"BFonc2011470_CR26","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/j.1365-2141.2010.08111.x","volume":"149","author":"JL Robertus","year":"2010","unstructured":"Robertus JL, Kluiver J, Weggemans C, Harms G, Reijmers RM, Swart Y et al. (2010). MiRNA profiling in B non-Hodgkin lymphoma: a MYC-related miRNA profile characterizes Burkitt lymphoma. Br J Haematol 149: 896\u2013899.","journal-title":"Br J Haematol"},{"key":"BFonc2011470_CR27","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1182\/blood-2009-05-220095","volume":"114","author":"KJ Savage","year":"2009","unstructured":"Savage KJ, Johnson NA, Ben-Neriah S, Connors JM, Sehn LH, Farinha P et al. (2009). MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy. Blood 114: 3533\u20133537.","journal-title":"Blood"},{"key":"BFonc2011470_CR28","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1038\/onc.2010.634","volume":"30","author":"E Sotillo","year":"2011","unstructured":"Sotillo E, Laver T, Mellert H, Schelter JM, Cleary MA, McMahon S et al. (2011). Myc overexpression brings out unexpected antiapoptotic effects of miR-34a. Oncogene 30: 2587\u20132594.","journal-title":"Oncogene"},{"key":"BFonc2011470_CR29","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1182\/blood-2009-09-243147","volume":"115","author":"JJ Zhao","year":"2010","unstructured":"Zhao JJ, Lin J, Lwin T, Yang H, Guo J, Kong W et al. (2010). microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood 115: 2630\u20132639.","journal-title":"Blood"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2011470.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2011470","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2011470.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T18:34:45Z","timestamp":1647887685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2011470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,17]]},"references-count":29,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2012,6,14]]}},"alternative-id":["BFonc2011470"],"URL":"https:\/\/doi.org\/10.1038\/onc.2011.470","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,17]]},"assertion":[{"value":"14 April 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}